Platelet membrane glucoprotein CD62p, CD63 expression and their clinical significance in patients with diabetes mellitus

李素梅,叶山东,莫蔚林,邢学农,戴海明,陈若平
DOI: https://doi.org/10.3969/j.issn.1000-0399.2002.03.010
2002-01-01
Abstract:Objective To investigate the changes of platelet α-granule membrane glycoprotein (CD62P), and platelet lysosomal granulemembrane glycoprotein(CD63) expression and their clinical significance in patients with type 2 diabetes mellitus(DM). Methods 68 type 2 diabetes mellitus (35 cases with angiopathy, 33 cases without angiopathy) and 31 normal individuals entered this study. The expression level of CD62P and CD63 were measured by flow cytometric immunoflurescence. Results The positive rate of CD62P and CD63 in type 2 diabetes mellitus were significantly higher than those in control group. The positive rate of platelet membrane glycoprotein CD62P and CD63 in type 2 diabetes mellitus patients with angiopathy were significantly higher than those of type 2 diabetes mellitus patients without angiopathy. Conclusion The measurement of expression levels of CD62P and CD63 has an important clinical value in early diagnosis of type 2 diabetes mellitus with angiopathy.
What problem does this paper attempt to address?